Population Pharmacokinetics Analysis of AMG 416, an Allosteric Activator of the Calcium-Sensing Receptor, in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis.
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Etelcalcetide (Primary)
- Indications Secondary hyperparathyroidism
- Focus Pharmacokinetics
- 08 Dec 2015 New trial record